• Home
  • Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant.

Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant.

Author List
Wu X, Kwong A, Heller M, Lokken RP, Fidelman N, Mehta N
Publication
Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society
Publication ID (Profile URL)
https://researcherprofiles.org/profile/432739945
Publication Year
2023
PubMed ID
37639286
Publication Title
Wu X, Kwong A, Heller M, Lokken RP, Fidelman N, Mehta N. Cost-effectiveness analysis of interventional liver-directed therapies for downstaging of hepatocellular carcinoma before liver transplant. Liver Transpl. 2023 Aug 29.